Human Milk Oligosaccharides (HMO) Market Analysis

Human Milk Oligosaccharides Market Analysis

To get key market trends

  Download Free Sample

The human milk oligosaccharides market from neutral HMO segment held over USD 122 million revenue in 2022. Neutral HMOs, like other HMOs, have prebiotic effects, supporting the growth of beneficial gut bacteria and promoting a healthy gut microbiome. A healthy gut microbiome is associated with improved gut health and enhanced immune system function. Neutral HMOs are known for their anti-adhesive properties, which means they can prevent pathogens from adhering to the intestinal lining.
 

The infant formula segment accounted for 40% of the human milk oligosaccharides market share in 2022. HMOs are naturally present in human breast milk and play a crucial role in infant gut health, immune system development, and protection against pathogens. The desire to provide similar health benefits to formula-fed infants drove the demand for HMOs in infant formula and baby foods. Research on HMOs has revealed their potential therapeutic applications, such as in reducing the risk of infections in preterm infants and supporting gut health in individuals with gastrointestinal disorders.
 

U.S. human milk oligosaccharides market size dominated around USD 62.72 million in 2022. North American consumers are increasingly focused on health and wellness, seeking products that offer functional benefits. HMOs are known for their potential gut health and immune system benefits, making them attractive to health-conscious consumers in the region.